Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 7th:
AMC Networks Inc. (AMCX - Free Report) : This owner and operator of various cable television brands has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 2.8% over the last 60 days.
AMC Networks Inc. Price and Consensus
AMC Networks’s shares gained 12.1% over the last one month more than S&P 500’s gain of 3.8%. The company possesses a Momentum Score of A.
AMC Networks Inc. Price
Akoustis Technologies, Inc. (AKTS - Free Report) : This designer and manufacturer of radio frequency (RF) filter products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 12% over the last 60 days.
Akoustis Technologies, Inc. Price and Consensus
Akoustis Technologies’ shares gained 18.6% over the last one month. The company possesses a Momentum Score of A.
Akoustis Technologies, Inc. Price
AcelRxPharmaceuticals, Inc. : This operator of a specialty pharmacy has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx’s shares gained 44% over the last one month. The company possesses a Momentum Score of A.
AcelRx Pharmaceuticals, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, June 7th:
AMC Networks Inc. (AMCX - Free Report) : This owner and operator of various cable television brands has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 2.8% over the last 60 days.
AMC Networks Inc. Price and Consensus
AMC Networks’s shares gained 12.1% over the last one month more than S&P 500’s gain of 3.8%. The company possesses a Momentum Score of A.
AMC Networks Inc. Price
Akoustis Technologies, Inc. (AKTS - Free Report) : This designer and manufacturer of radio frequency (RF) filter products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 12% over the last 60 days.
Akoustis Technologies, Inc. Price and Consensus
Akoustis Technologies’ shares gained 18.6% over the last one month. The company possesses a Momentum Score of A.
Akoustis Technologies, Inc. Price
AcelRxPharmaceuticals, Inc. : This operator of a specialty pharmacy has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx’s shares gained 44% over the last one month. The company possesses a Momentum Score of A.
AcelRx Pharmaceuticals, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on AMCX - FREE
Get the latest research report on AKTS - FREE